Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio

Fig. 3

Comparison of survival rates after stratification by PLR. After stratification, the patients were divided into in-Milan group, Milan ~ Hangzhou & PLR < 120 group, Milan ~ Hangzhou & PLR ≥ 120 group, and out-Hangzhou group. The 1-, 3-, and 5-year RFS of the Milan ~ Hangzhou & PLR < 120 group were comparable with that of the in-Milan group. The Milan ~ Hangzhou & PLR ≥ 120 group showed poor outcomes which were similar to those of the out-Hangzhou group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us